Sutro Biopharma (STRO) Amortizatization of Intangibles (2017 - 2025)

Sutro Biopharma (STRO) has disclosed Amortizatization of Intangibles for 9 consecutive years, with $531000.0 as the latest value for Q4 2025.

  • Quarterly Amortizatization of Intangibles fell 65.5% to $531000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.4 million through Dec 2025, down 64.66% year-over-year, with the annual reading at $3.4 million for FY2025, 64.66% down from the prior year.
  • Amortizatization of Intangibles hit $531000.0 in Q4 2025 for Sutro Biopharma, down from $755000.0 in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $3.1 million in Q4 2023 to a low of -$799000.0 in Q4 2021.
  • Historically, Amortizatization of Intangibles has averaged $990600.0 across 5 years, with a median of $1.1 million in 2025.
  • Biggest five-year swings in Amortizatization of Intangibles: tumbled 1309.76% in 2021 and later surged 2224.27% in 2023.
  • Year by year, Amortizatization of Intangibles stood at -$799000.0 in 2021, then surged by 246.93% to $1.2 million in 2022, then surged by 160.05% to $3.1 million in 2023, then tumbled by 49.59% to $1.5 million in 2024, then plummeted by 65.5% to $531000.0 in 2025.
  • Business Quant data shows Amortizatization of Intangibles for STRO at $531000.0 in Q4 2025, $755000.0 in Q3 2025, and $1.0 million in Q2 2025.